When was xMD founded?

xMD was founded in 2015 and raised its 1st funding round 2 years after it was founded.

Where is xMD located?

xMD is headquartered in Baltimore, United States.

How many employees does xMD have?

As of Jul 01, 2024, the latest employee count at xMD is 2.

Is xMD a funded company?

xMD is a funded company, having raised a total of $775K across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 29, 2017.

When was the latest funding round of xMD?

xMD's latest funding was a $***** Grant (prize money) round on Aug 23, 2021, with participation from 1 investor. Its primary sector is Life Sciences Platforms and Tools. In United States, the Life Sciences Platforms and Tools sector has seen $899M in funding in 2026 to date.

Where does xMD rank among its competitors?

xMD ranks 19th amongst 55 active competitors, of which 12 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Element Biosciences, which secured $175M in Jun, 2026.

Who are the top competitors of xMD?

xMD's top competitors include 10X Genomics, Cepheid and Complete Genomics. Among them, Element Biosciences secured the most recent funding round in June, 2026.

xMD - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of laboratory instruments and consumables for life science research. The company focused on developing molecular diagnostics tools for research, biopharmaceutical, and clinical laboratory markets. The company uses proprietary technology called Expression Microdissection enables the researcher and clinician to isolate, procure and enrich “cells of interest” from biopsy and other specimen samples.

Website: xmddiagnostics.com
Email ID: *****@xmddiagnostics.com
Phone Number: +1 **********

Key Metrics

Founded Year

2015

Location

Baltimore, United States

Stage

Seed

Total Funding

$775K in 4 rounds

Latest Funding Round

Grant (prize money), Aug 23, 2021, $*****

Investors

TEDCO & 3 more

Ranked

19^th among 55 active competitors

Employee Count

2 as on Jul 01, 2024

Similar Companies

10X Genomics & 63 more

View xMD's full profile

xMD has raised a total funding of $775K over 4 rounds. Its first funding round was on Mar 29, 2017. Its latest funding round was a Grant (prize money) round on Aug 23, 2021 for $*****. 1 investor participated in its latest round. xMD has 4 institutional investors.

Here is the list of recent funding rounds of xMD:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 23, 2021	1506865	Grant (prize money)	2156290	9543448	3815276	3430071
Oct 17, 2018	3833220	Seed	1840373	5661512	2139687	2487132
Dec 05, 2017	1344661	Seed	2764562	4017074	9911952	TEDCO

Access funding benchmarks and valuations. Sign up today!

View details of xMD's funding rounds and investors

The founders of xMD is Benjamin Shapiro.

Here are the details of xMD's key team members:

Benjamin Shapiro: Co-Founder of xMD.
Contact Info: 1 email address
Ting Pau Oei: CEO of xMD.
Contact Info: 1 email address

View details of xMD's Founder profiles and Board Members

xMD's employee count trend

xMD has 2 employees as of Jul 24. Here is xMD's employee count trend over the years:

Uncover xMD's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of xMD include 10X Genomics, Cepheid and Complete Genomics. Here is the list of Top 10 competitors of xMD, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	10X Genomics 2012, Pleasanton (United States), Public	Developer of single-cell, spatial, and in situ tools for high-resolution biological analysis	$243M	Fidelity Investments, Meritech & 14 others	77/100
2nd	Cepheid 1996, Sunnyvale (United States), Acquired	Developer of molecular diagnostic testing solutions	$19.1M	R H Capital Partners, CampVentures & 14 others	73/100
3rd	Complete Genomics 2006, San Jose (United States), Acquired	Developer of DNA sequencing platform for human genome sequencing and analysis	$125M	Enterprise Partners Venture Capital, Orbimed ... & 8 others	66/100
4th	Element Biosciences 2017, San Diego (United States), Series E	Developer of benchtop DNA sequencer for research applications	$853M	Meritech, Fidelity Investments & 12 others	64/100
5th	Fluidigm 1999, San Francisco (United States), Public	Developer of instruments for life sciences industries	$40.5M	Cross Creek, Versant Ventures & 16 others	55/100
6th	Nabsys 2004, Providence (United States), Acquired	Developer of tools to map whole genome sequencing	$145M	Hitachi High-Tech Corporation, Stata Venture Partners ... & 7 others	54/100
7th	Stratos Genomics 2007, Seattle (United States), Acquired	Nanopore-based single molecule sequencer	$62.9M	Stratos Group, Roche & 2 others	45/100
8th	Sage Science 2005, Beverly (United States), Seed	Laboratory and research-related technologies	$7.85M	NHGRI, Finney Capital & 2 others	40/100
9th	FluoroFinder 2008, Westminster (United States), Series A	Design and search tool to find the best flow cytometry products for the panel	$4.66M	CBSA, Innosphere & 1 others	40/100
10th	Helicos BioSciences 2002, Cambridge (United States), Deadpooled	DNA-sequencing instrument based on imaging individual DNA molecules.	$77M	Atlas Venture, Versant Ventures & 3 others	39/100
19th	xMD 2015, Baltimore (United States), Seed	Developer of laboratory instruments and consumables for life science research	$775K	TEDCO, Gore Range Capital & 2 others	31/100